TRPV1 Antagonism by Capsazepine Modulates Innate Immune Response in Mice Infected with Plasmodium berghei ANKA

TRPV1 Antagonism by Capsazepine Modulates Innate Immune Response in Mice Infected with Plasmodium berghei ANKA

Author Fernandes, Elizabeth S. Google Scholar
Brito, Carolina X. L. Google Scholar
Teixeira, Simone A. Google Scholar
Barboza, Renato Autor UNIFESP Google Scholar
Reis, Aramys S. dos Google Scholar
Azevedo-Santos, Ana Paula S. Google Scholar
Muscara, Marcelo Google Scholar
Costa, Soraia K. P. Google Scholar
Marinho, Claudio R. F. Google Scholar
Brain, Susan D. Google Scholar
Grisotto, Andmarcos A. G. Google Scholar
Institution Univ CEUMA
Kings Coll London
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Univ Fed Maranhao
Inst Florence Ensino Super
Abstract Thousands of people suffer from severe malaria every year. the innate immune response plays a determinant role in host's defence to malaria. Transient receptor potential vanilloid 1 (TRPV1) modulates macrophage-mediated responses in sepsis, but its role in other pathogenic diseases has never been addressed. We investigated the effects of capsazepine, a TRPV1 antagonist, in malaria. C57BL/6 mice received 10(5) red blood cells infected with Plasmodium berghei ANKA intraperitoneally. Noninfected mice were used as controls. Capsazepine or vehicle was given intraperitoneally for 6 days. Mice were culled on day 7 after infection and blood and spleen cell phenotype and activation were evaluated. Capsazepine decreased circulating but not spleen F4/80(+)Ly6G(+) cell numbers as well as activation of both F4/80(+) and F4/80(+)Ly6G(+) cells in infected animals. in addition, capsazepine increased circulating but not spleen GR1(+) and natural killer (NK) population, without interfering with natural killer T (NKT) cell numbers and blood NK and NKT activation. However, capsazepine diminished CD69 expression in spleen NKT but not NK cells. Infection increased lipid peroxidation and the release of TNF alpha and IFN gamma, although capsazepine-treated group exhibited lower levels of lipid peroxidation and TNF alpha. Capsazepine treatment did not affect parasitaemia. Overall, TRPV1 antagonism modulates the innate immune response to malaria.
Language English
Sponsor Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA; Brazil)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Date 2014-01-01
Published in Mediators of Inflammation. New York: Hindawi Publishing Corporation, 12 p., 2014.
ISSN 0962-9351 (Sherpa/Romeo, impact factor)
Publisher Hindawi Publishing Corporation
Extent 12
Origin http://dx.doi.org/10.1155/2014/506450
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000342942500001
URI http://repositorio.unifesp.br/handle/11600/37141

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account